General enquiries via WhatsApp+1 (956) 701-2764

Research information only · No sales · Not for human use

PURITY PEPSRESEARCH MATERIALS
Account disabled — demo only. No purchases or accounts.Cart disabled — demo only. No purchases or accounts.
Catalogue
Tirzepatide — rendered visual concept
Rendered visual concept — not inventory photography. Label text in imagery is decorative.

Metabolic

Tirzepatide

Currently unavailable

Dual GIP / GLP-1 receptor agonist

Strength
10 mg
Vial count
Unspecified
Strength of evidence
Approved medicine (specific indications)

Research summary

Synthetic peptide acting on both GIP and GLP-1 receptors; studied in phase 3 programs for type 2 diabetes and weight outcomes.

Regulatory status

Approved only as specific branded prescription products. Research material is not a substitute.

No certificate of analysis or purity figure is shown because none has been verified for this demo. No dosing information is provided.

Information only. Purchases and payments are disabled.

Regulatory notice (Canada): Labelling a product “for research use only” does not make it legal to sell unapproved injectable peptides. In Canada, drugs for human use require Health Canada authorization. This site is a non-transactional design demo: nothing is for sale, and nothing here is medical advice or dosing guidance.